Shivanta Impex

Nintedoc 100 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 100mg
International Trade Name: Ofev® / Vargatef®

Nintedoc 100 is a high-quality Nintedanib 100mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed as Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nintedoc 100 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.

Nintedanib is a small-molecule tyrosine kinase inhibitor that inhibits multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby slowing disease progression in fibrotic lung disorders and suppressing tumor angiogenesis. Nintedoc 100 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung diseases (ILDs), and non-small cell lung cancer (NSCLC) under specific therapeutic protocols.

High-ranking search keywords include: Nintedanib 100mg capsule, Nintedoc 100 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD medication, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.

Nintedoc 100 Nintedanib Soft Gelatin Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, and international pharmaceutical distributors.

Nindanib 150 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 150mg
International Trade Name: Ofev® / Vargatef®

Nindanib 150 is a high-quality Nintedanib 150mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed under the brand names Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nindanib 150 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.

Nintedanib is a small-molecule tyrosine kinase inhibitor that blocks multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby reducing fibrotic activity and inhibiting tumor angiogenesis. Nindanib 150 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung diseases (ILDs), and non-small cell lung cancer (NSCLC) in defined clinical settings.

High-ranking search keywords include: Nintedanib 150mg capsule, Nindanib 150 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.

Nindanib 150 Nintedanib Soft Gelatin Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with full regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, hospital supply chains, and international pharmaceutical distributors.

Nindanib 100 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 100mg
International Trade Name: Ofev® / Vargatef®

Nindanib 100 is a high-quality Nintedanib 100mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed under the brand names Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nindanib 100 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.

Nintedanib is a small-molecule tyrosine kinase inhibitor that inhibits multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby slowing disease progression in fibrotic lung disorders and suppressing tumor angiogenesis. Nindanib 100 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung diseases (ILDs), and non-small cell lung cancer (NSCLC) under defined therapeutic protocols.

High-ranking search keywords include: Nintedanib 100mg capsule, Nindanib 100 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD medication, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.

Nindanib 100 Nintedanib Soft Gelatin Capsules are manufactured under stringent GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, hospital procurement teams, and international pharmaceutical distributors.

Nintib 150 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 150mg
International Trade Name: Ofev® / Vargatef®

Nintib 150 is a high-quality Nintedanib 150mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed under the brand names Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nintib 150 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.

Nintedanib is a small-molecule tyrosine kinase inhibitor that blocks multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby reducing fibrotic activity and inhibiting tumor angiogenesis. Nintib 150 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung diseases (ILDs), and non-small cell lung cancer (NSCLC) in specific clinical settings.

High-ranking search keywords include: Nintedanib 150mg capsule, Nintib 150 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.

Nintib 150 Nintedanib Soft Gelatin Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with full regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, hospital procurement teams, and international pharmaceutical distributors.

Nintib 100 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 100mg
International Trade Name: Ofev® / Vargatef®

Nintib 100 is a high-quality Nintedanib 100mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed under the brand names Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nintib 100 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.

Nintedanib is a small-molecule tyrosine kinase inhibitor that blocks multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby reducing fibrotic activity and inhibiting tumor angiogenesis. Nintib 100 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung diseases (ILDs), and non-small cell lung cancer (NSCLC) in specific clinical settings.

High-ranking search keywords include: Nintedanib 100mg capsule, Nintib 100 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.

Nintib 100 Nintedanib Soft Gelatin Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, hospital procurement teams, and international pharmaceutical distributors.

Versavo 400 Solution for Infusion
Composition: Bevacizumab Solution for Infusion 400mg
International Trade Name: Avastin®

Versavo 400 is a high-quality Bevacizumab 400mg Solution for Infusion, a biosimilar/generic equivalent of the internationally recognized anti-VEGF monoclonal antibody marketed under the brand name Avastin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Versavo 400 is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs.

Bevacizumab is a recombinant humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), thereby suppressing tumor angiogenesis and reducing blood supply to cancer cells. Versavo 400 Solution for Infusion is indicated for the treatment of multiple malignancies, including colorectal cancer, non-small cell lung cancer (NSCLC), ovarian cancer, cervical cancer, renal cell carcinoma, and glioblastoma, in combination with standard chemotherapy regimens as per clinical guidelines.

High-ranking search keywords include: Bevacizumab 400mg infusion, Versavo 400 infusion, Avastin biosimilar, bevacizumab price, anti-VEGF therapy, oncology monoclonal antibody exporter India, bevacizumab supplier, and cancer biologics manufacturer India.

Versavo 400 Bevacizumab Solution for Infusion is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The infusion is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.

Perzea 420mg Injection
Composition: Pertuzumab Injection 420mg
International Trade Name: Perjeta®

Perzea 420 is a high-quality Pertuzumab 420mg Injection, a biosimilar/generic equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Perjeta®. Manufactured in WHO-GMP certified facilities following stringent biologics manufacturing standards, Perzea 420 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and breast cancer treatment programs.

Pertuzumab is a humanized monoclonal antibody that targets the HER2 receptor, specifically inhibiting HER2 dimerization with other HER family receptors. This dual HER2 blockade mechanism significantly reduces tumor cell proliferation and survival. Perzea 420 Injection is primarily indicated for the treatment of HER2-positive breast cancer, including metastatic breast cancer and early-stage breast cancer, in combination with trastuzumab and chemotherapy as per established treatment protocols.

High-ranking search keywords include: Pertuzumab 420mg injection, Perzea 420 injection, Perjeta biosimilar, pertuzumab price, HER2 positive breast cancer treatment, pertuzumab exporter India, oncology monoclonal antibody supplier, and breast cancer biologic manufacturer India.

Perzea 420 Pertuzumab Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, clinical efficacy, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.

Cizumab 100mg Injection
Composition: Bevacizumab Injection 100mg
International Trade Name: Avastin®

Cizumab 100 is a high-quality Bevacizumab 100mg Injection, a biosimilar/generic equivalent of the internationally recognized anti-VEGF monoclonal antibody marketed under the brand name Avastin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Cizumab 100 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs.

Bevacizumab is a recombinant humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), thereby suppressing tumor angiogenesis and reducing blood supply to cancer cells. Cizumab 100mg Injection is indicated for the treatment of multiple malignancies, including colorectal cancer, non-small cell lung cancer (NSCLC), ovarian cancer, cervical cancer, renal cell carcinoma, and glioblastoma, in combination with standard chemotherapy regimens as per clinical guidelines.

High-ranking search keywords include: Bevacizumab 100mg injection, Cizumab 100 injection, Avastin biosimilar, bevacizumab price, anti-VEGF therapy, oncology monoclonal antibody exporter India, bevacizumab supplier, and cancer biologics manufacturer India.

Cizumab 100 Bevacizumab Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.

Bevatas 300mg Solution for Infusion
Composition: Bevacizumab Solution for Infusion 300mg
International Trade Name: Avastin®

Bevatas 300 is a high-quality Bevacizumab 300mg Solution for Infusion, a biosimilar/generic equivalent of the internationally recognized anti-VEGF monoclonal antibody marketed under the brand name Avastin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Bevatas 300 is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs.

Bevacizumab is a recombinant humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), thereby suppressing tumor angiogenesis and limiting blood supply to cancer cells. Bevatas 300 Solution for Infusion is indicated for the treatment of several malignancies, including colorectal cancer, non-small cell lung cancer (NSCLC), ovarian cancer, cervical cancer, renal cell carcinoma, and glioblastoma, in combination with standard chemotherapy regimens according to clinical guidelines.

High-ranking search keywords include: Bevacizumab 300mg infusion, Bevatas 300 infusion, Avastin biosimilar, bevacizumab price, anti-VEGF therapy, oncology monoclonal antibody exporter India, bevacizumab supplier, and cancer biologics manufacturer India.

Bevatas 300 Bevacizumab Solution for Infusion is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The infusion is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.

Bosentas 125 – Bosentan Tablets | Trade Name: Tracleer

Shivanta Impex offers Bosentas 125 Tablets, premium Bosentan tablets widely used for pulmonary arterial hypertension (PAH) management and cardiovascular therapy. Trusted under the trade name Tracleer, this high-quality pharmaceutical product is ideal for wholesale, distribution, and export supply globally.

Bosentan 125mg Tablets, Bosentas Tablets, Tracleer, Pulmonary Arterial Hypertension Medicine, PAH Treatment, Cardiovascular Therapy Tablets, Heart Health Medicine, Pharmaceutical Export, Shivanta Impex.

Molnuvir 200 contains Molnupiravir 200 mg, an antiviral medication used for the treatment of mild to moderate viral infections, including COVID-19, in adults who are at risk of progressing to severe disease, as prescribed by a healthcare professional.

Molnupiravir works by inhibiting viral replication, helping reduce viral load and supporting faster recovery. Internationally, Molnupiravir is known under the reference brand Lagevrio, making Molnuvir 200 a trusted and widely used antiviral option.

• Contains Molnupiravir 200 mg

• Antiviral action against RNA viruses

• Helps reduce risk of disease progression

• Oral capsule for easy administration

• Clinically tested and globally used

• Brand Name: Molnuvir 200

• Generic Name: Molnupiravir

• Strength: 200 mg

• Dosage Form: Capsules

• Reference Brand: Lagevrio

• Indication: Viral infections (as prescribed)

Molnuvir 200, Molnupiravir capsules 200 mg, Lagevrio alternative, buy Molnupiravir capsules, antiviral Molnupiravir, Molnupiravir 200 mg price, COVID antiviral capsules.

• Manufactured by licensed pharmaceutical companies

• Quality-assured and export-ready

• Cost-effective alternative to branded Lagevrio

• Trusted by healthcare providers worldwide

Q1. What is Molnuvir 200 used for?
Molnuvir 200 is used to treat viral infections, including COVID-19, under medical supervision.

Q2. Is Molnuvir the same as Lagevrio?
Molnuvir contains the same active ingredient, Molnupiravir, as the reference brand Lagevrio.

Q3. How should Molnupiravir be taken?
It should be taken exactly as prescribed by a doctor, usually for a fixed treatment duration.

Q4. Is this product genuine?
Yes, it is sourced from approved manufacturers with proper quality documentation.

Q5. Do you supply internationally?
Yes, international supply is available, subject to local regulations and approvals.

Nintedoc 150 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 150mg
International Trade Name: Ofev® / Vargatef®

Nintedoc 150 is a high-quality Nintedanib 150mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed as Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nintedoc 150 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.

Nintedanib is a small-molecule tyrosine kinase inhibitor that targets multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby inhibiting pathways involved in fibrosis progression and tumor angiogenesis. Nintedoc 150 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, and non-small cell lung cancer (NSCLC) in specific clinical settings.

High-ranking search keywords include: Nintedanib 150mg capsule, Nintedoc 150 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.

Nintedoc 150 Nintedanib Soft Gelatin Capsules are manufactured under stringent GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with appropriate regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, and international pharmaceutical distributors.

Nintedoc 150 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 150mg
International Trade Name: Ofev® / Vargatef®

Nintedoc 150 is a high-quality Nintedanib 150mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed as Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nintedoc 150 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.

Nintedanib is a small-molecule tyrosine kinase inhibitor that targets multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby inhibiting pathways involved in fibrosis progression and tumor angiogenesis. Nintedoc 150 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, and non-small cell lung cancer (NSCLC) in specific clinical settings.

High-ranking search keywords include: Nintedanib 150mg capsule, Nintedoc 150 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.

Nintedoc 150 Nintedanib Soft Gelatin Capsules are manufactured under stringent GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with appropriate regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, and international pharmaceutical distributors.

Bosentas – Bosentan 125mg Tablets | Trade Name: Tracleer

Shivanta Impex presents Bosentas, premium Bosentan 125mg tablets widely used for the management of pulmonary arterial hypertension (PAH). Available under the trusted trade name Tracleer, this high-quality pharmaceutical product is ideal for distributors, wholesalers, and exporters seeking reliable Bosentan tablets for domestic and international supply.

Bosentan 125mg Tablets, Bosentas Tablets, Tracleer, Pulmonary Arterial Hypertension Medicine, PAH Treatment Tablets, Cardiovascular Therapy, Pharmaceutical Export, Shivanta Impex.

Celdaz 200 mg Injection
Composition: Dacarbazine 200 mg Injection
International Trade Name: DTIC-Dome

Celdaz 200 mg is a premium Dacarbazine injection supplied by Shivanta Impex, a trusted pharmaceutical exporter from India. This formulation contains Dacarbazine 200 mg, an alkylating antineoplastic agent internationally recognized under the brand name DTIC-Dome, widely used in the treatment of malignant melanoma, Hodgkin’s lymphoma, and soft tissue sarcomas.

Celdaz 200 mg injection, Dacarbazine 200 mg injection, DTIC-Dome generic injection, Dacarbazine exporter India, Dacarbazine bulk supplier, oncology Dacarbazine injection, and Dacarbazine manufacturer India.

Manufactured under stringent GMP standards, Celdaz 200 mg ensures consistent quality, accurate concentration, and sterile, export-grade packaging, making it suitable for global pharmaceutical distribution and oncology markets.

Domvel 60 mg PFS Injection
Composition: Denosumab 60 mg / 1 ml Pre-Filled Syringe
International Trade Name: Prolia / Xgeva

Domvel 60 mg PFS is a premium Denosumab injection supplied by Shivanta Impex, a trusted pharmaceutical exporter from India. This formulation contains Denosumab 60 mg in a 1 ml pre-filled syringe, a fully human monoclonal antibody internationally recognized under the brand names Prolia and Xgeva. It is widely used in the treatment of osteoporosis, bone loss associated with cancer therapy, and prevention of skeletal-related events in patients with bone metastases.

Domvel 60 mg injection, Denosumab 60 mg PFS, Prolia generic injection, Xgeva generic injection, Denosumab exporter India, Denosumab bulk supplier, oncology and bone health Denosumab injection, and Denosumab manufacturer India.

Manufactured under stringent GMP standards, Domvel 60 mg PFS ensures consistent quality, precise dosage, and sterile, export-grade packaging, making it suitable for global pharmaceutical distribution and specialty care markets.

Calbitin 4 mg Injection
Composition: Topotecan 4 mg Injection
International Trade Name: Hycamtin

Calbitin 4 mg is a premium Topotecan injection supplied by Shivanta Impex, a trusted pharmaceutical exporter from India. This formulation contains Topotecan 4 mg, a topoisomerase I inhibitor internationally recognized under the brand name Hycamtin, widely used in the treatment of ovarian cancer, small cell lung cancer (SCLC), and other solid tumors.

Calbitin 4 mg injection, Topotecan 4 mg injection, Hycamtin generic injection, Topotecan exporter India, Topotecan bulk supplier, oncology Topotecan injection, and Topotecan manufacturer India.

Manufactured under stringent GMP standards, Calbitin 4 mg ensures consistent quality, accurate concentration, and sterile, export-grade packaging, making it suitable for global pharmaceutical distribution and oncology markets.

Adrim 50 mg Injection
Composition: Doxorubicin 50 mg Injection
International Trade Name: Doxorubicin

Adrim 50 mg is a premium Doxorubicin injection supplied by Shivanta Impex, a trusted pharmaceutical exporter from India. This formulation contains Doxorubicin 50 mg, an anthracycline antineoplastic agent widely recognized for its efficacy in treating breast cancer, leukemia, lymphoma, sarcomas, and other solid tumors.

Adrim 50 mg injection, Doxorubicin 50 mg injection, Doxorubicin generic injection, Doxorubicin exporter India, Doxorubicin bulk supplier, oncology Doxorubicin injection, and Doxorubicin manufacturer India.

Manufactured under stringent GMP standards, Adrim 50 mg ensures consistent quality, accurate concentration, and sterile, export-grade packaging, making it suitable for global pharmaceutical distribution and oncology markets.

Darberel 100 mcg PFS Injection
Composition: Darbepoetin Alfa Injection 100 mcg/0.5 ml (Pre-Filled Syringe)
International Trade Name: Aranesp®

Darberel 100 mcg PFS is a high-quality Darbepoetin Alfa 100 mcg Injection, a biosimilar/generic equivalent of the internationally recognized erythropoiesis-stimulating agent (ESA) marketed under the brand name Aranesp®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Darberel 100 mcg Injection is supplied by trusted pharmaceutical exporters from India to support global nephrology, oncology, and hematology treatment programs.

Darbepoetin alfa is a long-acting recombinant erythropoietin analog that stimulates red blood cell production by activating erythropoietin receptors in the bone marrow. Darberel 100 mcg PFS Injection is primarily indicated for the treatment of anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia in cancer patients, helping reduce the need for blood transfusions when used according to clinical guidelines.

High-ranking search keywords include: Darbepoetin alfa 100 mcg injection, Darberel 100 mcg PFS, Aranesp biosimilar, darbepoetin price, anemia treatment injection, CKD anemia therapy, darbepoetin exporter India, and erythropoiesis stimulating agent supplier.

Darberel 100 mcg Darbepoetin Alfa Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The pre-filled syringe (0.5 ml) format allows accurate dosing and ease of administration. The product is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for dialysis centers, oncology hospitals, government supply programs, specialty distributors, and international pharmaceutical procurement channels.

Vivitra 375mg Injection
Composition: Trastuzumab Injection 375mg
International Trade Name: Herceptin®

Vivitra 375 is a high-quality Trastuzumab 375mg Injection, a biosimilar/generic equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Herceptin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Vivitra 375 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and breast cancer treatment programs.

Trastuzumab is a humanized monoclonal antibody that selectively binds to the HER2 receptor, inhibiting HER2-mediated signaling pathways and inducing antibody-dependent cellular cytotoxicity (ADCC). Vivitra 375 Injection is primarily indicated for the treatment of HER2-positive breast cancer and HER2-positive gastric or gastroesophageal junction adenocarcinoma, administered alone or in combination with chemotherapy according to established treatment protocols.

High-ranking search keywords include: Trastuzumab 375mg injection, Vivitra 375 injection, Herceptin biosimilar, trastuzumab price, HER2 positive breast cancer treatment, trastuzumab exporter India, oncology monoclonal antibody supplier, and breast cancer biologic manufacturer India.

Vivitra 375 Trastuzumab Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.

Canmab 150mg Injection
Composition: Trastuzumab Injection 150mg
International Trade Name: Herceptin®

Canmab 150 is a high-quality Trastuzumab 150mg Injection, a biosimilar equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Herceptin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Canmab 150 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and breast cancer treatment programs.

Trastuzumab is a humanized monoclonal antibody that selectively binds to the HER2 receptor, inhibiting HER2-mediated signaling pathways and inducing antibody-dependent cellular cytotoxicity (ADCC). Canmab 150 Injection is primarily indicated for the treatment of HER2-positive breast cancer and HER2-positive gastric or gastroesophageal junction adenocarcinoma, administered alone or in combination with chemotherapy as per established treatment protocols.

High-ranking search keywords include: Trastuzumab 150mg injection, Canmab 150 injection, Herceptin biosimilar, trastuzumab price, HER2 positive breast cancer treatment, trastuzumab exporter India, oncology monoclonal antibody supplier, and breast cancer biologic manufacturer India.

Canmab 150 Trastuzumab Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.

Z-Taxel 300mg Injection
Composition: Paclitaxel Injection 300mg
International Trade Name: Taxol®

Z-Taxel 300 is a high-quality Paclitaxel 300mg Injection, a generic equivalent of the internationally recognized taxane-class chemotherapeutic agent marketed under the brand name Taxol®. Manufactured in WHO-GMP certified facilities, Z-Taxel 300 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs.

Paclitaxel is an antimicrotubule antineoplastic agent that promotes microtubule assembly and stabilizes them against depolymerization, thereby inhibiting normal microtubule dynamics required for cell division. Z-Taxel 300 Injection is primarily indicated for the treatment of breast cancer, ovarian cancer, non-small cell lung cancer (NSCLC), Kaposi’s sarcoma, and other solid tumors, either as monotherapy or in combination with other chemotherapeutic agents as per established protocols.

High-ranking search keywords include: Paclitaxel 300mg injection, Z-Taxel 300 injection, Taxol generic, paclitaxel price, taxane chemotherapy, oncology injectable exporter India, paclitaxel supplier, and anticancer injection manufacturer India.

Z-Taxel 300 Paclitaxel Injection is manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The injection is supplied in secure, export-grade packaging with appropriate regulatory documentation, making it suitable for hospital oncology departments, cancer treatment centers, government supply programs, and international pharmaceutical distributors.

Decmax Dexamethasone 8mg Tablet
Composition: Dexamethasone Tablets 8mg
International Trade Names: Decadron® / Ozurdex® / Dexycu®

Decmax is a high-quality Dexamethasone 8mg Tablet, a generic equivalent of the internationally recognized corticosteroid marketed under well-known brand names such as Decadron®, Ozurdex®, and Dexycu® (different formulations and indications). Manufactured in WHO-GMP certified facilities, Decmax Tablets are supplied by trusted pharmaceutical exporters from India to support global hospital, oncology, immunology, and specialty care treatment programs.

Dexamethasone is a potent synthetic glucocorticoid with strong anti-inflammatory, immunosuppressive, and anti-edema properties. Decmax 8mg Tablets are widely indicated for the management of inflammatory and autoimmune disorders, allergic reactions, cerebral edema, hematological malignancies, and as a supportive medication in oncology for chemotherapy-induced nausea, hypersensitivity prevention, and tumor-related inflammation.

High-ranking search keywords include: Dexamethasone 8mg tablet, Decmax tablet, Decadron generic tablet, dexamethasone price, corticosteroid tablet, anti-inflammatory steroid, oncology supportive care drug, dexamethasone exporter India, and GMP steroid tablet manufacturer.

Decmax Dexamethasone 8mg Tablets are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The tablets are supplied in secure, export-grade packaging with appropriate regulatory documentation, making them suitable for hospitals, oncology centers, intensive care units, specialty clinics, government supply programs, and international pharmaceutical distributors.

Metaginase 10,000 IU Injection
Composition: L-Asparaginase Injection 10,000 IU
International Trade Name: Elspar®

Metaginase 10,000 IU is a high-quality L-Asparaginase 10,000 IU Injection, a generic equivalent of the internationally recognized antineoplastic enzyme therapy marketed under the brand name Elspar®. Manufactured in WHO-GMP certified facilities, Metaginase Injection is supplied by trusted pharmaceutical exporters from India to support global pediatric and adult oncology treatment programs.

L-Asparaginase is an antileukemic enzyme that catalyzes the hydrolysis of L-asparagine to aspartic acid and ammonia. Leukemic lymphoblasts lack sufficient asparagine synthetase and depend on external asparagine for survival. By depleting circulating asparagine, Metaginase 10,000 IU Injection selectively inhibits protein synthesis in malignant cells, leading to apoptosis. It is primarily indicated for the treatment of acute lymphoblastic leukemia (ALL) as part of combination chemotherapy regimens.

High-ranking search keywords include: L-Asparaginase 10000 IU injection, Metaginase injection, Elspar generic, asparaginase price, acute lymphoblastic leukemia treatment, pediatric leukemia drug, oncology enzyme therapy, L-asparaginase exporter India, and anticancer injection manufacturer India.

Metaginase 10,000 IU L-Asparaginase Injection is manufactured under strict GMP quality standards, ensuring high enzymatic activity, consistent potency, and long-term stability. The injection is supplied in secure, export-grade packaging with appropriate regulatory documentation, making it suitable for pediatric oncology units, hematology departments, cancer hospitals, government supply programs, and international pharmaceutical distributors.

Rascase 1.5mg Injection
Composition: Rasburicase Injection 1.5mg
International Trade Name: Elitek®

Rascase 1.5 is a high-quality Rasburicase 1.5mg Injection, a generic equivalent of the internationally recognized recombinant urate oxidase enzyme therapy marketed under the brand name Elitek®. Manufactured in WHO-GMP certified facilities, Rascase Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and hematology supportive care programs.

Rasburicase is a recombinant urate oxidase enzyme that rapidly converts uric acid into the more soluble metabolite allantoin, which is easily excreted by the kidneys. Rascase 1.5mg Injection is primarily indicated for the prevention and treatment of hyperuricemia associated with tumor lysis syndrome (TLS) in pediatric and adult patients receiving cytotoxic chemotherapy for leukemia, lymphoma, and other rapidly proliferating malignancies.

High-ranking search keywords include: Rasburicase 1.5mg injection, Rascase injection, Elitek generic, rasburicase price, tumor lysis syndrome treatment, hyperuricemia management, oncology supportive care drug, rasburicase exporter India, and recombinant enzyme injection supplier.

Rascase 1.5mg Rasburicase Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring enzymatic activity, consistent potency, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for oncology wards, hematology units, pediatric cancer centers, government tenders, and international pharmaceutical supply chains.

Doxorex PL 2mg is a high-quality Liposomal Doxorubicin 2mg Injection, a generic equivalent of the internationally recognized pegylated liposomal anthracycline formulation marketed under the brand name Doxil®. Manufactured in WHO-GMP certified facilities using advanced liposomal drug delivery technology, Doxorex PL Injection is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs.

Liposomal doxorubicin is an encapsulated formulation of doxorubicin designed to enhance tumor targeting while reducing systemic toxicity. The liposomal delivery system prolongs circulation time and lowers cardiotoxicity compared to conventional doxorubicin. Doxorex PL 2mg Injection is primarily indicated for the treatment of ovarian cancer, multiple myeloma, Kaposi’s sarcoma, and breast cancer in specific clinical settings.

High-ranking search keywords include: Liposomal doxorubicin 2mg injection, Doxorex PL injection, Doxil generic, pegylated liposomal doxorubicin price, anthracycline chemotherapy, oncology injectable exporter India, and liposomal anticancer drug manufacturer India.

Doxorex PL 2mg Liposomal Doxorubicin Injection is manufactured under strict GMP quality standards, ensuring liposome integrity, consistent drug encapsulation, accurate dosing, and long-term stability. The injection is supplied in secure, export-grade packaging with appropriate regulatory documentation, making it suitable for hospital oncology departments, cancer institutes, government supply programs, and international pharmaceutical distributors.

Doxorex 50mg Injection
Composition: Doxorubicin Hydrochloride Injection 50mg
International Trade Name: Adriamycin®

Doxorex 50 is a high-quality Doxorubicin 50mg Injection, a generic equivalent of the internationally recognized anthracycline antineoplastic agent marketed under the brand name Adriamycin®. Manufactured in WHO-GMP certified facilities, Doxorex 50 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and hematology treatment programs.

Doxorubicin is an anthracycline antibiotic that intercalates DNA, inhibits topoisomerase II, and generates free radicals, leading to inhibition of DNA replication and apoptosis of rapidly dividing cancer cells. Doxorex 50mg Injection is widely indicated for the treatment of breast cancer, lymphomas, leukemias, sarcomas, ovarian cancer, and various other solid tumors, either as monotherapy or in combination chemotherapy regimens.

High-ranking search keywords include: Doxorubicin 50mg injection, Doxorex 50 injection, Adriamycin generic, doxorubicin price, anthracycline chemotherapy, oncology injectable exporter India, and anticancer injection manufacturer India.

Doxorex 50 Doxorubicin Injection is manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The injection is supplied in secure, export-grade packaging with appropriate regulatory documentation, making it suitable for hospital oncology departments, cancer treatment centers, government supply programs, and international pharmaceutical distributors.

Leucorin 50mg Injection
Composition: Calcium Leucovorin Injection 50mg (Folinic Acid)
International Trade Name: Leucovorin® / Folinic Acid

Leucorin 50 is a high-quality Calcium Leucovorin 50mg Injection, a generic equivalent of the internationally recognized folinic acid rescue therapy used in oncology and hematology practice. Manufactured in WHO-GMP certified facilities, Leucorin 50 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology supportive care and chemotherapy optimization programs.

Calcium leucovorin (folinic acid) is a reduced folate that bypasses dihydrofolate reductase inhibition. Leucorin 50mg Injection is primarily indicated for rescue therapy following high-dose methotrexate, modulation of fluorouracil (5-FU) therapy to enhance antitumor activity, and for the treatment of folate deficiency anemia when oral therapy is not feasible.

High-ranking search keywords include: Calcium leucovorin 50mg injection, Leucorin 50 injection, folinic acid injection, leucovorin price, methotrexate rescue therapy, 5-FU modulation, oncology supportive care drug, leucovorin exporter India, and chemotherapy antidote manufacturer India.

Leucorin 50 Calcium Leucovorin Injection is manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The injection is supplied in secure, export-grade packaging with appropriate regulatory documentation, making it suitable for hospital oncology departments, chemotherapy infusion centers, hematology units, government supply programs, and international pharmaceutical distributors.

Fludamax 50mg Injection
Composition: Fludarabine Phosphate Injection 50mg
International Trade Name: Fludara®

Fludamax 50 is a high-quality Fludarabine 50mg Injection, a generic equivalent of the internationally recognized purine nucleoside analog marketed under the brand name Fludara®. Manufactured in WHO-GMP certified facilities, Fludamax Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and hematology treatment programs.

Fludarabine is a purine analog antineoplastic agent that inhibits DNA synthesis by interfering with DNA polymerase, ribonucleotide reductase, and DNA primase, leading to apoptosis of rapidly dividing lymphoid cells. Fludamax 50mg Injection is primarily indicated for the treatment of chronic lymphocytic leukemia (CLL), and it may be used in certain non-Hodgkin’s lymphomas as part of combination chemotherapy regimens.

High-ranking search keywords include: Fludarabine 50mg injection, Fludamax 50 injection, Fludara generic, fludarabine price, chronic lymphocytic leukemia treatment, hematology injectable exporter India, oncology drug supplier, and purine analog anticancer injection manufacturer India.

Fludamax 50 Fludarabine Injection is manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for hematology and oncology centers, hospital chemotherapy units, government supply programs, and international pharmaceutical distributors.

Carzomib 60mg Injection
Composition: Carfilzomib Injection 60mg
International Trade Name: Kyprolis®

Carzomib 60 is a high-quality Carfilzomib 60mg Injection, a generic equivalent of the internationally recognized proteasome inhibitor marketed under the brand name Kyprolis®. Manufactured in WHO-GMP certified facilities, Carzomib Injection is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs, particularly in hematologic malignancies.

Carfilzomib is a selective proteasome inhibitor that irreversibly binds to the chymotrypsin-like site of the 20S proteasome, leading to disruption of protein homeostasis, apoptosis, and inhibition of cancer cell proliferation. Carzomib 60mg Injection is primarily indicated for the treatment of relapsed and refractory multiple myeloma, either as monotherapy or in combination with dexamethasone and other chemotherapeutic agents.

High-ranking search keywords include: Carfilzomib 60mg injection, Carzomib 60 injection, Kyprolis generic, carfilzomib price, multiple myeloma treatment, proteasome inhibitor injection, oncology injectable exporter India, and anticancer drug manufacturer India.

Carzomib 60mg Injection is manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for hematology and oncology centers, hospital chemotherapy units, government supply programs, and international pharmaceutical distributors.

Reditux 500mg Injection
Composition: Rituximab Injection 500mg
International Trade Name: Rituxan®

Reditux 500 is a high-quality Rituximab 500mg Injection, a biosimilar of the internationally renowned anti-CD20 monoclonal antibody marketed under the brand name Rituxan®. Manufactured in WHO-GMP certified facilities, Reditux Injection is supplied by trusted pharmaceutical exporters from India to support global oncology, hematology, and immunology treatment programs.

Rituximab is a chimeric monoclonal antibody that selectively targets the CD20 antigen expressed on B-lymphocytes, leading to B-cell lysis through complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), and induction of apoptosis. Reditux 500mg Injection is primarily indicated for the treatment of non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukemia (CLL), and is also widely used in autoimmune disorders such as rheumatoid arthritis in combination therapy.

High-ranking search keywords include: Rituximab 500mg injection, Reditux 500 injection, Rituxan biosimilar, rituximab price, non-Hodgkin lymphoma treatment, CD20 monoclonal antibody, oncology biologics exporter India, and biosimilar manufacturer India.

Reditux 500 Rituximab Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology and hematology centers, infusion clinics, government supply programs, and international pharmaceutical distributors.

Cresp 200 mcg Injection
Composition: Darbepoetin alfa Injection 200 mcg
International Trade Name: Nespo®

Cresp 200 is a high-quality Darbepoetin alfa 200 mcg Injection, a biosimilar equivalent of the internationally recognized erythropoiesis-stimulating agent (ESA) marketed under the brand name Nespo®. Manufactured in WHO-GMP certified facilities, Cresp Injection is supplied by trusted pharmaceutical exporters from India to support global nephrology, oncology, and hematology treatment programs.

Darbepoetin alfa is a long-acting recombinant erythropoietin analog that stimulates red blood cell production by binding to erythropoietin receptors in bone marrow. Cresp 200 mcg Injection is primarily indicated for the treatment of anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia in cancer patients, helping reduce the need for blood transfusions and improve patient quality of life.

High-ranking search keywords include: Darbepoetin alfa 200 mcg injection, Cresp 200 injection, Nespo biosimilar, darbepoetin price, anemia in chronic kidney disease, chemotherapy-induced anemia treatment, ESA injection exporter India, and biologic manufacturer India.

Cresp 200 Darbepoetin alfa Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent potency, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for dialysis centers, oncology units, hospitals, government supply programs, and international pharmaceutical distributors.

Cresp 40 mcg Injection
Composition: Darbepoetin alfa Injection 40 mcg
International Trade Name: Nespo®

Cresp 40 is a high-quality Darbepoetin alfa 40 mcg Injection, a biosimilar equivalent of the internationally recognized erythropoiesis-stimulating agent (ESA) marketed under the brand name Nespo®. Manufactured in WHO-GMP certified facilities, Cresp Injection is supplied by reliable pharmaceutical exporters from India to support global nephrology, oncology, and hematology treatment programs.

Darbepoetin alfa is a long-acting recombinant erythropoietin analog that stimulates red blood cell production by activating erythropoietin receptors in the bone marrow. Cresp 40 mcg Injection is primarily indicated for the treatment of anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia in cancer patients, helping to reduce transfusion requirements and improve hemoglobin levels.

High-ranking search keywords include: Darbepoetin alfa 40 mcg injection, Cresp 40 injection, Nespo biosimilar, darbepoetin price, anemia in CKD treatment, chemotherapy-induced anemia injection, ESA exporter India, and biologic manufacturer India.

Cresp 40 Darbepoetin alfa Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for dialysis centers, oncology units, hospitals, government tenders, and international pharmaceutical distributors.

Darberel 200 mcg PFS Injection
Composition: Darbepoetin Alfa Injection 200 mcg/0.4 ml (Pre-Filled Syringe)
International Trade Name: Aranesp®

Darberel 200 mcg PFS is a high-quality Darbepoetin Alfa 200 mcg Injection, a biosimilar/generic equivalent of the internationally recognized erythropoiesis-stimulating agent (ESA) marketed under the brand name Aranesp®. Manufactured in WHO-GMP certified facilities under stringent biologics manufacturing standards, Darberel 200 mcg Injection is supplied by trusted pharmaceutical exporters from India to support global nephrology, oncology, and hematology treatment programs.

Darbepoetin alfa is a long-acting recombinant erythropoietin analog that stimulates red blood cell production by activating erythropoietin receptors in the bone marrow. Darberel 200 mcg PFS Injection is primarily indicated for the treatment of anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia in cancer patients, helping reduce the need for blood transfusions when administered according to established clinical guidelines.

High-ranking search keywords include: Darbepoetin alfa 200 mcg injection, Darberel 200 mcg PFS, Aranesp biosimilar, darbepoetin price, anemia treatment injection, CKD anemia therapy, darbepoetin exporter India, and erythropoiesis stimulating agent supplier.

Darberel 200 mcg Darbepoetin Alfa Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The pre-filled syringe (0.4 ml) format allows precise dosing and ease of administration. The product is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for dialysis centers, oncology hospitals, government supply programs, specialty distributors, and international pharmaceutical procurement channels.

Peg Religrast Injection
Composition: Pegfilgrastim Injection 6mg
International Trade Name: Neulasta®

Peg Religrast is a high-quality Pegfilgrastim 6mg Injection, a biosimilar equivalent of the long-acting granulocyte colony-stimulating factor (G-CSF) marketed under the brand name Neulasta®. Manufactured in WHO-GMP certified facilities, Peg Religrast Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and hematology supportive-care programs.

Pegfilgrastim is a pegylated recombinant human G-CSF that stimulates the production, maturation, and activation of neutrophils in the bone marrow. Its prolonged half-life allows once-per-chemotherapy-cycle dosing. Peg Religrast Injection is primarily indicated for the prevention of chemotherapy-induced neutropenia and reduction of febrile neutropenia risk in cancer patients receiving myelosuppressive chemotherapy.

High-ranking search keywords include: Pegfilgrastim 6mg injection, Peg Religrast injection, Neulasta biosimilar, pegfilgrastim price, chemotherapy-induced neutropenia treatment, long-acting G-CSF injection, oncology supportive care exporter India, and biologic manufacturer India.

Peg Religrast Pegfilgrastim Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent potency, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology centers, chemotherapy units, hospitals, government supply programs, and international pharmaceutical distributors.

Denosteorel 60mg Injection
Composition: Denosumab Injection 60mg
International Trade Name: Prolia®

Denosteorel 60 is a high-quality Denosumab 60mg Injection, a biosimilar equivalent of the internationally recognized RANKL inhibitor monoclonal antibody marketed under the brand name Prolia®. Manufactured in WHO-GMP certified facilities, Denosteorel Injection is supplied by trusted pharmaceutical exporters from India to support global bone-health, oncology supportive-care, and endocrinology treatment programs.

Denosumab is a fully human monoclonal antibody that binds to and inhibits RANK ligand (RANKL), preventing osteoclast formation, function, and survival, thereby reducing bone resorption and increasing bone mass. Denosteorel 60mg Injection is primarily indicated for the treatment of osteoporosis in postmenopausal women and men at high fracture risk, bone loss associated with hormone ablation therapy, and glucocorticoid-induced osteoporosis.

High-ranking search keywords include: Denosumab 60mg injection, Denosteorel 60 injection, Prolia biosimilar, denosumab price, osteoporosis treatment injection, RANKL inhibitor therapy, bone health injectable exporter India, and monoclonal antibody manufacturer India.

Denosteorel 60 Denosumab Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for orthopedic clinics, endocrinology units, oncology supportive-care centers, hospitals, government tenders, and international pharmaceutical distributors.

Abcixirel 10mg Injection
Composition: Abciximab Injection 10mg
International Trade Name: ReoPro®

Abcixirel 10 is a high-quality Abciximab 10mg Injection, a biosimilar equivalent of the internationally recognized glycoprotein IIb/IIIa inhibitor marketed under the brand name ReoPro®. Manufactured in WHO-GMP certified facilities, Abcixirel Injection is supplied by trusted pharmaceutical exporters from India to support global cardiology and interventional treatment programs.

Abciximab is a chimeric monoclonal antibody Fab fragment that blocks the platelet glycoprotein IIb/IIIa receptor, preventing fibrinogen binding and platelet aggregation. Abcixirel 10mg Injection is primarily indicated as an adjunct to percutaneous coronary intervention (PCI) for the prevention of ischemic cardiac complications, including in patients with unstable angina and acute coronary syndromes.

High-ranking search keywords include: Abciximab 10mg injection, Abcixirel injection, ReoPro biosimilar, abciximab price, glycoprotein IIb/IIIa inhibitor, PCI antiplatelet injection, cardiology injectable exporter India, and critical care biologic manufacturer India.

Abcixirel 10 Abciximab Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent potency, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for cardiac catheterization labs, coronary care units (CCU), tertiary hospitals, government supply programs, and international pharmaceutical distributors.

Darberel 40 mcg PFS Injection
Composition: Darbepoetin alfa Injection 40 mcg (Pre-Filled Syringe)
International Trade Name: Aranesp®

Darberel 40 is a high-quality Darbepoetin alfa 40 mcg Pre-Filled Syringe Injection, a biosimilar equivalent of the internationally recognized erythropoiesis-stimulating agent (ESA) marketed under the brand name Aranesp®. Manufactured in WHO-GMP certified facilities, Darberel Injection is supplied by trusted pharmaceutical exporters from India to support global nephrology, oncology, and hematology treatment programs.

Darbepoetin alfa is a long-acting recombinant erythropoietin analog that stimulates red blood cell production by activating erythropoietin receptors in the bone marrow. Darberel 40 mcg PFS Injection is primarily indicated for the treatment of anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia in cancer patients, helping reduce transfusion dependency and improve hemoglobin levels.

High-ranking search keywords include: Darbepoetin alfa 40 mcg injection, Darberel 40 PFS, Aranesp biosimilar, darbepoetin alfa price, CKD anemia treatment, chemotherapy-induced anemia injection, ESA exporter India, and biologic injectable manufacturer India.

Darberel 40 Darbepoetin alfa PFS Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent potency, safety, and long-term stability. The product is supplied in secure, cold-chain compliant, export-grade packaging, making it suitable for dialysis centers, oncology units, hospitals, government tenders, and international pharmaceutical distributors.

Ujvira 160mg Injection
Composition: Trastuzumab Emtansine Injection 160mg
International Trade Name: Kadcyla®

Ujvira 160 is a high-quality Trastuzumab Emtansine 160mg Injection, a biosimilar equivalent of the internationally recognized HER2-targeted antibody–drug conjugate (ADC) marketed under the brand name Kadcyla®. Manufactured in WHO-GMP certified facilities, Ujvira Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in HER2-positive breast cancer.

Trastuzumab emtansine (T-DM1) combines the HER2-targeting monoclonal antibody trastuzumab with the potent cytotoxic agent DM1 (emtansine), enabling targeted delivery of chemotherapy directly to HER2-overexpressing cancer cells. Ujvira 160mg Injection is primarily indicated for the treatment of HER2-positive metastatic or early breast cancer, especially in patients previously treated with trastuzumab and taxane-based therapy.

High-ranking search keywords include: Trastuzumab emtansine 160mg injection, Ujvira 160 injection, Kadcyla biosimilar, T-DM1 price, HER2-positive breast cancer treatment, ADC oncology injection, biologics exporter India, and anticancer monoclonal antibody manufacturer India.

Ujvira 160 Trastuzumab Emtansine Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Vivitra 150mg Injection
Composition: Trastuzumab Injection 150mg
International Trade Name: Herceptin®

Vivitra 150 is a high-quality Trastuzumab 150mg Injection, a biosimilar equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Herceptin®. Manufactured in WHO-GMP certified facilities, Vivitra Injection is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs, particularly in HER2-positive cancers.

Trastuzumab is a humanized monoclonal antibody that selectively binds to the HER2/neu receptor, inhibiting tumor cell proliferation and mediating antibody-dependent cell-mediated cytotoxicity (ADCC). Vivitra 150mg Injection is primarily indicated for the treatment of HER2-positive breast cancer (early-stage and metastatic) and HER2-positive gastric or gastroesophageal junction adenocarcinoma, either as monotherapy or in combination chemotherapy regimens.

High-ranking search keywords include: Trastuzumab 150mg injection, Vivitra 150 injection, Herceptin biosimilar, trastuzumab price, HER2-positive breast cancer treatment, monoclonal antibody oncology injection, biologics exporter India, and biosimilar manufacturer India.

Vivitra 150 Trastuzumab Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.